The Metalloprotease Meprin β Is an Alternative β-Secretase of APP
- PMID: 28105004
- PMCID: PMC5215381
- DOI: 10.3389/fnmol.2016.00159
The Metalloprotease Meprin β Is an Alternative β-Secretase of APP
Abstract
The membrane bound metalloprotease meprin β is important for collagen fibril assembly in connective tissue formation and for the detachment of the intestinal mucus layer for proper barrier function. Recent proteomic studies revealed dozens of putative new substrates of meprin β, including the amyloid precursor protein (APP). It was shown that APP is cleaved by meprin β in distinct ways, either at the β-secretase site resulting in increased levels of Aβ peptides, or at the N-terminus releasing 11 kDa, and 20 kDa peptide fragments. The latter event was discussed to be rather neuroprotective, whereas the ectodomain shedding of APP by meprin β reminiscent to BACE-1 is in line with the amyloid hypothesis of Alzheimer's disease, promoting neurodegeneration. The N-terminal 11 kDa and 20 kDa peptide fragments represent physiological cleavage products, since they are found in human brains under different diseased or non-diseased states, whereas these fragments are completely missing in brains of meprin β knock-out animals. Meprin β is not only a sheddase of adhesion molecules, such as APP, but was additionally demonstrated to cleave within the prodomain of ADAM10. Activated ADAM10, the α-secretase of APP, is then able to shed meprin β from the cell surface thereby abolishing the β-secretase activity. All together meprin β seems to be a novel player in APP processing events, even influencing other enzymes involved in APP cleavage.
Keywords: APP; N-terminal truncated Aβ; meprin β; proteolysis; shedding.
Figures


Similar articles
-
Regulation of the alternative β-secretase meprin β by ADAM-mediated shedding.Cell Mol Life Sci. 2019 Aug;76(16):3193-3206. doi: 10.1007/s00018-019-03179-1. Epub 2019 Jun 14. Cell Mol Life Sci. 2019. PMID: 31201463 Free PMC article. Review.
-
Phosphorylation of the amyloid precursor protein (APP) at Ser-675 promotes APP processing involving meprin β.J Biol Chem. 2019 Nov 22;294(47):17768-17776. doi: 10.1074/jbc.RA119.008310. Epub 2019 Oct 11. J Biol Chem. 2019. PMID: 31604820 Free PMC article.
-
The metalloprotease meprin β generates amino terminal-truncated amyloid β peptide species.J Biol Chem. 2012 Sep 28;287(40):33304-13. doi: 10.1074/jbc.M112.395608. Epub 2012 Aug 9. J Biol Chem. 2012. PMID: 22879596 Free PMC article.
-
Generation of aggregation prone N-terminally truncated amyloid β peptides by meprin β depends on the sequence specificity at the cleavage site.Mol Neurodegener. 2016 Feb 19;11:19. doi: 10.1186/s13024-016-0084-5. Mol Neurodegener. 2016. PMID: 26895626 Free PMC article.
-
The metalloproteases meprin α and meprin β: unique enzymes in inflammation, neurodegeneration, cancer and fibrosis.Biochem J. 2013 Mar 1;450(2):253-64. doi: 10.1042/BJ20121751. Biochem J. 2013. PMID: 23410038 Free PMC article. Review.
Cited by
-
From Small Peptides to Large Proteins against Alzheimer'sDisease.Biomolecules. 2022 Sep 22;12(10):1344. doi: 10.3390/biom12101344. Biomolecules. 2022. PMID: 36291553 Free PMC article. Review.
-
Amyloid Precursor Protein: A Regulatory Hub in Alzheimer's Disease.Aging Dis. 2024 Feb 1;15(1):201-225. doi: 10.14336/AD.2023.0308. Aging Dis. 2024. PMID: 37307834 Free PMC article. Review.
-
Cathepsin B Deficiency Improves Memory Deficits and Reduces Amyloid-β in hAβPP Mouse Models Representing the Major Sporadic Alzheimer's Disease Condition.J Alzheimers Dis. 2023;93(1):33-46. doi: 10.3233/JAD-221005. J Alzheimers Dis. 2023. PMID: 36970896 Free PMC article. Review.
-
Contribution of the Endosomal-Lysosomal and Proteasomal Systems in Amyloid-β Precursor Protein Derived Fragments Processing.Front Cell Neurosci. 2018 Nov 22;12:435. doi: 10.3389/fncel.2018.00435. eCollection 2018. Front Cell Neurosci. 2018. PMID: 30524243 Free PMC article.
-
Discovery and Optimization of Selective Inhibitors of Meprin α (Part I).Pharmaceuticals (Basel). 2021 Feb 28;14(3):203. doi: 10.3390/ph14030203. Pharmaceuticals (Basel). 2021. PMID: 33671080 Free PMC article.
References
-
- Alzheimer A. (1907). Über eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift Psychiatr. Physc. Gerichtliche Medizin. 64, 146–148.
-
- Asai M., Hattori C., Iwata N., Saido T. C., Sasagawa N., Szabó B., et al. . (2006). The novel beta-secretase inhibitor KMI-429 reduces amyloid beta peptide production in amyloid precursor protein transgenic and wild-type mice. J. Neurochem. 96, 533–540. 10.1111/j.1471-4159.2005.03576.x - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources